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Response to Knoppers et al.
We appreciate the interest by Knoppers et al. in the issues
raised by our study.1 We agree with the authors of this
letter on anonymity as a ‘‘valid and vital concept’’ that
‘‘may need to be reconceptualized to remain relevant in
21st century science and medicine.’’ We share the concerns
of the authors on a nuanced treatment of the subject, but
they make some points on which we would elaborate.
Knoppers et al. argue that ‘‘reidentification risks are
minimal’’ in genome-wide association studies that are
presently being conducted. We note that although the
theoretical probabilities of reidentification and phenotype
reconstruction are real2–5 and increase, in some cases quite
substantially, with the number of phenotypes included in
a study (as, for example, with the present use of -omics
technologies),1 it nevertheless remains unclear that mali-
cious attempts to reidentify subjects and/or to reconstruct
their phenotypes will ever be anything but exceedingly
rare. We recognize that despite their rarity, reidentification
events may have unanticipated consequences (e.g., for the
study participants and, possibly, for the public perception
of genomics research). All things considered, however, we
agree that the overall risk of reidentification is likely to be
minimal. Moreover, any harm associated with reidentifica-
tion would be quite variable depending on the phenotypes
included in the study, and factors such as the ages and
temperaments of participants, and should in many situa-
tions be minimal as well. Knoppers et al. also state that
‘‘models currently exist that facilitate dissemination of
useful health data without compromising privacy,’’ and
we agree that dbGaP policies do indeed facilitate data
dissemination without compromising study participant
privacy.6 But current policies at dbGaP (and other data
repositories) hold dissemination of results of genome
investigations to the same standards as dissemination of
individual-level data. These restrictive policies reverse
long-standing traditions that complete results of published
studies should be readily available to the scientific commu-
nity for inspection, and we believe that they genuinely
impede research progress as well. The harm to society
(including study participants) associated with slowing,
and perhaps sometimes preventing, research discoveries
because results of expensive, taxpayer-funded studies are
not broadly disseminated should also be considered in
determining policies for dissemination of results.
Our conviction is that results of genome studies should
always be broadly disseminated unless there are veryThe Americangood reasons to require more restricted dissemination. At
the very least, results from large-scale genome studies
should be easily accessible to investigators who certify on
a regular basis that they will make no attempt to reidentify
study participants. We have always served results of our
genome studies not involving human subjects (studies
on cell lines in the public arena) in public-access databases
(e.g., http://www.scandb.org and http://www.PACdb.org)
and are now transmitting complete results of our genome
studies on human subjects to dbGaP in hopes that policies
there will soon permit broad and less restrictive dissemina-
tion of those results to the scientific community. We hope
that others will join us.
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